| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 206.68M | 204.50M | 188.83M | 171.32M | 135.24M | 129.31M |
| Gross Profit | 149.01M | 142.37M | 134.52M | 120.94M | 91.90M | 88.81M |
| EBITDA | 145.81M | 222.32M | 122.46M | 708.26M | 272.77M | 104.42M |
| Net Income | 130.50M | 201.89M | 73.33M | 697.27M | 265.19M | 92.58M |
Balance Sheet | ||||||
| Total Assets | 3.11B | 3.03B | 2.75B | 2.67B | 1.84B | 1.62B |
| Cash, Cash Equivalents and Short-Term Investments | 7.22M | 8.77M | 8.33M | 8.61M | 12.32M | 51.42M |
| Total Debt | 462.82M | 410.33M | 512.27M | 438.66M | 353.37M | 418.67M |
| Total Liabilities | 519.91M | 463.72M | 569.54M | 486.00M | 388.40M | 452.44M |
| Stockholders Equity | 2.59B | 2.57B | 2.18B | 2.18B | 1.45B | 1.16B |
Cash Flow | ||||||
| Free Cash Flow | 51.53M | 114.57M | 5.56M | 2.42M | 4.39M | 10.52M |
| Operating Cash Flow | 112.37M | 114.57M | 111.98M | 107.57M | 77.40M | 74.26M |
| Investing Cash Flow | -99.52M | -27.67M | -106.23M | -171.00M | -72.72M | -48.42M |
| Financing Cash Flow | -11.23M | -87.50M | -6.02M | 59.71M | -43.77M | 7.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £1.58B | 4.93 | 12.27% | 5.71% | 4.80% | 37.75% | |
75 Outperform | £3.81B | 3.98 | 7.75% | 5.85% | -20.83% | ― | |
68 Neutral | £1.77B | 6.40 | 5.06% | 4.54% | 1.81% | -51.09% | |
68 Neutral | £1.49B | 12.28 | 4.88% | 4.25% | 1.66% | 11.42% | |
67 Neutral | £1.26B | 7.07 | 10.25% | 3.62% | -8.66% | 553.35% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
57 Neutral | £726.34M | -2.68 | -5.24% | 7.31% | -1.67% | -120.18% |